Oregovomab, CAS 213327-37-8

Product Description: Oregovomab (Alt-2 monoclonal antibody) is a murine mAb targeting CA125. Oregovomab induces cytotoxic immune response against CA125 expressing tumor cells[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Pietragalla A, et al. Oregovomab: an investigational agent for the treatment of advanced ovarian cancer. Expert Opin Investig Drugs. 2021 Feb;30(2):103-110. /[2]Sparholt MH, et al. Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic? APMIS. 2013 Jan;121(1):38-44.

CAS Number: 213327-37-8

Molecular Weight: N/A

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Transmembrane Glycoprotein

• Artikelnummer: MEXHY-P99409-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99409-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated